This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
1 - 2 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
0.7 mL (Note: This volume does not allow for repeat testing.)
Gel-barrier tube (preferred) or red-top tube
If a red-top tube is used, transfer separated serum to a plastic transport tube.
The MB isoenzyme of CK is most commonly elevated in acute myocardial infarction (AMI). In AMI, plasma CK-MB typically rises some four to six hours after the onset of chest pains, peaks within 12 to 24 hours, and returns to baseline levels within 24 to 48 hours. The pattern of serial CK-MB determinations is more informative than a single determination.
Citrate plasma specimen; improper labeling
Confirm and monitor therapy after acute myocardial infarction
Electrochemiluminescence immunoassay (ECLIA)
• Male: 0.0−10.4 ng/mL
• Female: 0.0−5.3 ng/mL
Creatine kinase (CK) is an enzyme, found primarily in muscle and brain tissue, which exists as three dimeric isoenzymes: CK-MM (CK-3), CK-MB (CK-2), and CK-BB (CK-1) − built from subunits designated M and B. The CK-MB isoenzyme, which has a molecular mass of approximately 87 kilodaltons, accounts for 5% to 50% of total CK activity in myocardium. In skeletal muscle, by contrast, it normally accounts for ≤1%, CK-MM being the dominant form, though the percentage can be as high as 10% in conditions reflecting skeletal muscle injury and regeneration (eg, severe exercise, muscular dystrophy, polymyositis).1
CK-MB is one of the most important myocardial markers (in spite of not being altogether cardiac-specific), with well-established roles in confirming acute myocardial infarction (AMI) and in monitoring reperfusion during thrombolytic therapy following AMI.1
In AMI, plasma CK-MB typically rises some four to six hours after the onset of chest pains, peaks within 12 to 24 hours, and returns to baseline levels within 24 to 48 hours. The pattern of serial CK-MB determinations is more informative than a single determination: one CK-MB measurement, even when taken at an appropriate time, cannot definitively confirm or rule out the occurrence of AMI. High levels might reflect skeletal injury rather than myocardial damage. A value within the reference range might be significant if it represents an increase from the patient's baseline level. (Low baseline levels are sometimes encountered in the elderly.) Accordingly, it has been recommended that CK-MB be measured on admission to the emergency room and at intervals thereafter (eg, at three-hour intervals over a six-hour to nine-hour period in patients with nonspecific electrocardiogram changes;1,2 or at six-hour to eight-hour intervals over a 24-hour period and more frequently if thrombolytic therapy has been instituted).1
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|120816||Creatine Kinase (CK), MB||13969-1||120817||Creatine Kinase (CK), MB||ng/mL||13969-1|
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf